Principal Financial Group Inc. Sells 411,358 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Principal Financial Group Inc. trimmed its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 65.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 213,583 shares of the company’s stock after selling 411,358 shares during the period. Principal Financial Group Inc. owned approximately 0.23% of Acadia Healthcare worth $6,476,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of ACHC. Signaturefd LLC boosted its position in shares of Acadia Healthcare by 460.6% during the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock worth $48,000 after buying an additional 1,004 shares during the period. Quadrant Capital Group LLC lifted its stake in Acadia Healthcare by 287.1% in the 4th quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company’s stock valued at $50,000 after acquiring an additional 933 shares in the last quarter. UMB Bank n.a. boosted its position in Acadia Healthcare by 149.5% during the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company’s stock worth $38,000 after acquiring an additional 755 shares during the last quarter. State of Wyoming bought a new position in shares of Acadia Healthcare during the 4th quarter worth approximately $56,000. Finally, Covestor Ltd raised its holdings in shares of Acadia Healthcare by 27.2% in the fourth quarter. Covestor Ltd now owns 1,450 shares of the company’s stock valued at $58,000 after purchasing an additional 310 shares during the last quarter.

Analysts Set New Price Targets

Several brokerages recently commented on ACHC. KeyCorp reduced their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating for the company in a report on Wednesday, May 14th. Barclays lowered their target price on Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating on the stock in a research report on Wednesday, May 14th. Mizuho dropped their target price on Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating on the stock in a report on Wednesday, May 14th. Stephens upgraded Acadia Healthcare to a “hold” rating in a research note on Monday, June 2nd. Finally, Guggenheim began coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They set a “buy” rating and a $36.00 price target on the stock. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $47.94.

Acadia Healthcare Stock Performance

Shares of NASDAQ ACHC opened at $22.68 on Thursday. Acadia Healthcare Company, Inc. has a one year low of $20.36 and a one year high of $82.41. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.35 and a quick ratio of 1.35. The firm has a market cap of $2.09 billion, a price-to-earnings ratio of 11.17, a P/E/G ratio of 4.43 and a beta of 0.93. The stock’s fifty day moving average price is $23.14 and its two-hundred day moving average price is $30.43.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a net margin of 5.94% and a return on equity of 8.72%. The business had revenue of $770.51 million during the quarter, compared to analysts’ expectations of $769.90 million. During the same quarter in the previous year, the company earned $0.84 EPS. The business’s revenue was up .3% on a year-over-year basis. On average, equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.